boston scientific corp sales are predicted to rise by despite stent woes boston scientific corp said it expects to report fourth quarter sales of about &# billion including sales of &# million from its drug coated stent business which has been pressured by clotting concerns the stent sales outlook represents a &# million drop from the year earlier total and a fall of &# million from the third quarter stents are tiny mesh devices that prop open arteries coated stents use medication to combat cell growth that can renarrow arteries and lead to complications concern mounted last year that coated stents could also cause a slightly elevated risk of clots the natick mass medical device makers total sales estimate is a increase over reported sales of &# billion in last years fourth quarter 
